ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million

ANI Pharma (ANIP) Misses Q1 EPS by 31c, Offers Guidance

May 10, 2022 6:54 AM EDT

ANI Pharma (NASDAQ: ANIP) reported Q1 EPS of ($0.12), $0.31 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $64.5 million versus the consensus estimate of $68.03 million.

GUIDANCE:

ANI Pharma sees FY2022 EPS of $1.34-$1.62, versus the consensus... More